Idiopathic Normal Pressure Hydrocephalus

3

Review clinical trials related to Idiopathic Normal Pressure Hydrocephalus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research

Participants needed: 40
Trial details
Age: 60-90Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Age ≥ 60 years; [+2]

Combining AD and Parkinson's disease and other nervous system diseases [+2]

Status: Recruiting

Integrated Multimodal Assessment to Optimize Diagnosis and Surgical Selection in Idiopathic Normal Pressure Hydrocephalus

Idiopathic normal pressure hydrocephalus (iNPH) is a neurological condition that can cause walking difficulties, cognitive impairment, and urinary incontinence. Although iNPH can be treated with cerebrospinal fluid (CSF) shunt surgery, diagnosis is often challenging because its symptoms and brain imaging findings may overlap with those of other neurodegenerative disorders, such as Alzheimer's disease or vascular parkinsonism. As a result, some patients may experience delayed diagnosis or may not be referred for potentially beneficial surgical treatment. This observational study aims to evaluate whether combining different types of clinical information can improve the diagnosis of iNPH and help identify patients who are more likely to benefit from surgery. The study integrates cognitive testing, motor performance assessment, CSF biomarker analysis, and brain magnetic resonance imaging. Patients aged over 60 years with suspected iNPH who are evaluated within a standardized diagnostic care pathway will be included. Cognitive and motor performance will be assessed before and after a cerebrospinal fluid tap test, which is part of routine clinical practice. Results will be compared between patients who receive a confirmed diagnosis of iNPH and undergo CSF shunt surgery and patients who receive an alternative diagnosis and do not undergo surgical treatment. The results of this study may help improve diagnostic accuracy, reduce false-negative test results, and support better clinical decision-making in patients with suspected idiopathic normal pressure hydrocephalus.

Participants needed: 116
Trial details
Age: 60-85Biological sex: AllType: ObservationalSponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoUpdated: Feb 23, 2026Locations: 2
Eligibility criteria

Age 60 years or older. [+2]

Refusal or inability to provide informed consent.

Status: Recruiting

Clinical Outcome in Patients With INPH

The aim of this study is to determine the clinical spectrum and natural progression of idiopathic normal pressure hydrocephalus (iNPH ) and related disorders in a prospective single center study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the etiology and molecular mechanisms of these diseases.

Participants needed: 200
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Xuanwu Hospital, BeijingUpdated: May 24, 2024Locations: 1Duration: 2 Years
Eligibility criteria

patients who was diagnosed as idiopathic normal pressure hydrocephalus

patient received surgical treatment or interventional treatment before patient i...